Evidence map›Paper›PMID 34201683›Full record

ReviewInternational journal of molecular sciences2021

Ammar Akram Kamarudin, Nor Hafiza Sayuti, Norazalina Saad, Nor Asma Ab Razak, Norhaizan Mohd Esa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. In Vitro Propagation ofTheScientificWorldJournal · 2025
    Article
  3. OptimizedInternational journal of ophthalmology · 2025
    Article
  4. Article
  5. Article
  6. The Antiproliferative Effect of Chloroform Fraction ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Antiosteoarthritis activities of 70% ethanol extract ofJournal of public health in Africa · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ammar Akram KamarudinNatural Medicine and Product Research Laboratory (NaturMeds), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.ORCID 0000-0001-7240-5806
Nor Hafiza SayutiNatural Medicine and Product Research Laboratory (NaturMeds), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Norazalina SaadLaboratory of Cancer Research UPM-MAKNA (CANRES), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.
Nor Asma Ab RazakNatural Medicine and Product Research Laboratory (NaturMeds), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.ORCID 0000-0002-3562-7052
Norhaizan Mohd EsaNatural Medicine and Product Research Laboratory (NaturMeds), Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia.ORCID 0000-0003-1545-0306

Funding

Universiti Putra Malaysia UPM/700-2/1/GPB/2017/9549900
6 · The paper itself

Abstract

Natural product is an excellent candidate for alternative medicine for disease management. The bulb of

Indexed as

AnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsHumansIridaceaePlant ExtractsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsPlant ExtractsbioactiveE. bulbosaindustrial applicationsIridaceaepharmacology

Identifiers

PMID34201683
PMCPMC8268349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.